Miltenyi, 150-000-478, Mobilized leukopak, G-CSF + plerixafor, 5 days, apheresis day 6&7

Mobilized leukopaks are enriched leukapheresis products collected under IRB-approved protocols using the Spectra Optia® Apheresis System. Donors receive granulocyte colony-stimulating factor (G-CSF), plerixafor, or both to mobilize CD34⁺ HSPCs into peripheral blood. Flexible mobilization schedules are available, including 4–5 day regimens with collection on day 5 or 6, or dual collections on days 5 & 6 or 6 & 7.
All donors are screened negative for HIV, HBV, and HCV. For added study relevance, donor characteristics such as BMI category, smoking status, or ethnicity can be specified upon request. Contact your local sales representative or our Technical Support team for more information.

Overview
Mobilized leukopaks are enriched leukapheresis products collected under IRB-approved protocols using the Spectra Optia® Apheresis System. Donors receive granulocyte colony-stimulating factor (G-CSF), plerixafor, or both to mobilize CD34⁺ HSPCs into peripheral blood. Flexible mobilization schedules are available, including 4–5 day regimens with collection on day 5 or 6, or dual collections on days 5 & 6 or 6 & 7.Mobilized leukopaks are enriched leukapheresis products collected under IRB-approved protocols using the Spectra Optia® Apheresis System. Donors receive granulocyte colony-stimulating factor (G-CSF), plerixafor, or both to mobilize CD34⁺ HSPCs into peripheral blood. Flexible mobilization schedules are available, including 4–5 day regimens with collection on day 5 or 6, or dual collections on days 5 & 6 or 6 & 7.